Tvardi Therapeutics, Inc. (TVRD)
0.8571
-0.01
(-0.86%)
USD |
NASDAQ |
Nov 06, 10:07
Tvardi Therapeutics Market Cap : 8.041M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 8.110M |
| November 04, 2026 | 8.081M |
| November 03, 2026 | 7.832M |
| November 02, 2026 | 7.555M |
| October 30, 2026 | 7.438M |
| October 29, 2026 | 8.096M |
| October 28, 2026 | 8.323M |
| October 27, 2026 | 8.118M |
| October 26, 2026 | 7.90M |
| October 23, 2026 | 8.818M |
| October 22, 2026 | 9.120M |
| October 21, 2026 | 9.569M |
| October 20, 2026 | 9.306M |
| October 19, 2026 | 9.100M |
| October 16, 2026 | 9.475M |
| October 15, 2026 | 10.04M |
| October 14, 2026 | 9.381M |
| October 13, 2026 | 9.757M |
| October 12, 2026 | 9.944M |
| October 09, 2026 | 9.663M |
| October 08, 2026 | 10.13M |
| October 07, 2026 | 10.32M |
| October 06, 2026 | 10.13M |
| October 05, 2026 | 10.69M |
| October 02, 2026 | 10.79M |
| Date | Value |
|---|---|
| October 01, 2026 | 11.63M |
| September 30, 2026 | 11.73M |
| September 29, 2026 | 12.01M |
| September 28, 2026 | 12.48M |
| September 25, 2026 | 11.91M |
| September 24, 2026 | 9.944M |
| September 23, 2026 | 12.38M |
| September 22, 2026 | 14.73M |
| September 21, 2026 | 15.10M |
| September 18, 2026 | 15.29M |
| September 17, 2026 | 15.20M |
| September 16, 2026 | 16.23M |
| September 15, 2026 | 16.51M |
| September 14, 2026 | 17.17M |
| September 11, 2026 | 17.54M |
| September 10, 2026 | 17.21M |
| September 09, 2026 | 17.36M |
| September 08, 2026 | 18.20M |
| September 04, 2026 | 17.92M |
| September 03, 2026 | 17.36M |
| September 02, 2026 | 17.64M |
| September 01, 2026 | 16.37M |
| August 31, 2026 | 16.89M |
| August 28, 2026 | 17.07M |
| August 27, 2026 | 16.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.612B |
| Corcept Therapeutics, Inc. | 8.091B |
| Veru, Inc. | 35.29M |
| Johnson & Johnson | 652.52B |
| Eli Lilly & Co. | 1.286T |
Market Cap Related Metrics
| Price to Book Value | 0.9593 |
| Price | 0.8571 |
| Earnings Yield | -324.2% |